Henry Schein Inc
$ 78.83
2.10%
17 Apr - close price
- Market Cap 8,859,697,000 USD
- Current Price $ 78.83
- High / Low $ 79.96 / 78.03
- Stock P/E 23.61
- Book Value 28.03
- EPS 3.27
- Next Earning Report 2026-05-04
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.09 %
- 52 Week High 89.29
- 52 Week Low 61.95
About
Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.
Analyst Target Price
$90.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-18 | 2025-11-04 | 2025-08-05 | 2025-05-05 | 2025-02-25 | 2024-11-05 | 2024-08-06 | 2024-05-07 | 2024-02-27 | 2023-11-13 | 2023-08-07 | 2023-05-09 |
| Reported EPS | 1.34 | 1.38 | 1.1 | 1.15 | 1.19 | 1.22 | 1.23 | 1.1 | 0.66 | 1.32 | 1.31 | 1.21 |
| Estimated EPS | 1.3 | 1.28 | 1.19 | 1.1101 | 1.2089 | 1.17 | 1.22 | 1.01 | 0.69 | 1.32 | 1.28 | 1.23 |
| Surprise | 0.04 | 0.1 | -0.09 | 0.0399 | -0.0189 | 0.05 | 0.01 | 0.09 | -0.03 | 0 | 0.03 | -0.02 |
| Surprise Percentage | 3.0769% | 7.8125% | -7.563% | 3.5943% | -1.5634% | 4.2735% | 0.8197% | 8.9109% | -4.3478% | 0% | 2.3438% | -1.626% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-04 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 1.2 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: HSIC
2026-04-17 17:16:00
Henry Schein Inc. (HSIC) saw its stock rise by 2.10% to $78.83 on a strong trading day, outperforming the broader market indices like the S&P 500 and Dow Jones Industrial Average. Despite the gain, the company's shares closed 11.71% below its 52-week high of $89.29. The article highlights the company's strong performance within a positive market session.
2026-04-17 13:07:48
Citigroup has upgraded Henry Schein (NASDAQ:HSIC) to a "Strong-Buy" rating with a $100 price target, suggesting a significant upside. This upgrade follows the company's strong quarterly earnings, where it surpassed revenue and EPS estimates and provided positive FY2026 guidance. Despite recent insider stock sales, institutional investors hold a substantial majority of the company's shares.
2026-04-17 12:39:35
Dentsply Sirona Inc. is highlighted for its dominant position in high-margin dental consumables, providing resilient growth and defensive appeal for investors, particularly in the U.S. and English-speaking markets. The article emphasizes the company's stable recurring revenue from essential dental products and its strategic investments in digital dentistry, which are expected to drive future growth. Despite potential supply chain issues and competition, Dentsply Sirona's broad portfolio, market leadership, and financial stability make it an attractive long-term investment.
2026-04-17 09:07:49
BTIG has initiated coverage of Henry Schein (HSIC) with a neutral recommendation. This indicates that BTIG analysts see the stock as neither overvalued nor undervalued at its current price. Investors will likely watch for future research or company developments to determine potential movements.
2026-04-17 00:37:49
Citigroup has initiated coverage of Henry Schein (HSIC) stock, issuing a buy recommendation. This new coverage suggests a positive outlook from Citigroup on the company's future performance and stock value.
2026-04-17 00:37:49
BTIG has initiated coverage on Henry Schein (HSIC.US) with a Hold rating. This indicates that BTIG's current recommendation for investors is to neither buy nor sell the stock, suggesting a neutral outlook on its near-term performance.
